학술논문

Imatinib and beyond - The new CML study IV. A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after interferon-alpha failure in newly diagnosed chronic phase chronic myeloid leukemia
Document Type
Article
Source
In: Annals of Hematology. (Annals of Hematology, April 2004, 83(4):258-264)
Subject
Language
English
ISSN
09395555